SEC
Whistleblower
Advocates

March 25, 2015

Biochemics, Inc.

Offering Fraud

SANCTION AMOUNT: $17,897,884

Defendants: Biochemics, Inc.

Misrepresentations in offering of interests in company, luring investments of at least $9 million from approximately 70 investors. Among other things, investors were falsely told that the company had ongoing, valuable collaborations with pharma companies and drugs under FDA review, and had been independently valued at between $500 million and $2 billion.

Thank you for submitting some email to us.